Quadrant Capital Group LLC Forma Therapeutics Holdings, Inc. Transaction History

Quadrant Capital Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$5.1 - $10.0 $1,249 - $2,450	245 New	245 $2,000
Q1 2022 May 06, 2022	SELL	$8.34 - $14.69 $4,170 - $7,345	-500 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$13.6 - $24.89 $2,720 - $4,978	200 Added 66.67%	500 $7,000
Q3 2021 Nov 12, 2021	SELL	$21.22 - $25.7 $403 - $488	-19 Reduced 5.96%	300 $7,000
Q2 2021 Aug 09, 2021	BUY	$22.86 - $30.95 $2,720 - $3,683	119 Added 59.5%	319 $8,000
Q3 2020 Nov 13, 2020	BUY	$32.95 - $50.25 $6,590 - $10,050	200 New	200 $10,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.